13.77
price up icon3.53%   0.47
after-market After Hours: 13.77
loading
Optimizerx Corp stock is traded at $13.77, with a volume of 50,047. It is up +3.53% in the last 24 hours and up +6.09% over the past month. OptimizeRx Corp is engaged in the healthcare market in the United States. It provides digital health messaging via electronic health records, providing a direct channel for pharmaceutical companies to communicate with healthcare providers and patients. The cloud-based solution supports patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and clinical information. Its product offerings are Financial Messaging, Brand and Clinical Messaging, Brand Support, and Patient Engagement.
See More
Previous Close:
$13.30
Open:
$13.49
24h Volume:
50,047
Relative Volume:
0.18
Market Cap:
$254.68M
Revenue:
$62.81M
Net Income/Loss:
$-13.75M
P/E Ratio:
-17.21
EPS:
-0.8
Net Cash Flow:
$153.00K
1W Performance:
-2.82%
1M Performance:
+6.09%
6M Performance:
+155.00%
1Y Performance:
+35.00%
1-Day Range:
Value
$13.49
$13.84
1-Week Range:
Value
$12.71
$14.96
52-Week Range:
Value
$3.78
$15.71

Optimizerx Corp Stock (OPRX) Company Profile

Name
Name
Optimizerx Corp
Name
Phone
248-651-6558
Name
Address
260 CHARLES STREET, WALTHAM, MI
Name
Employee
129
Name
Twitter
@OpRxTweets
Name
Next Earnings Date
2025-03-12
Name
Latest SEC Filings
Name
OPRX's Discussions on Twitter

Compare OPRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
OPRX
Optimizerx Corp
13.77 245.98M 62.81M -13.75M 153.00K -0.80
Health Information Services icon
VEEV
Veeva Systems Inc
286.01 46.61B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
64.86 10.57B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
96.91 8.42B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
61.00 11.13B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
WAY
Waystar Holding Corp
36.96 6.33B 906.14M -52.62M 89.62M -0.3621

Optimizerx Corp Stock (OPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-08-25 Downgrade RBC Capital Mkts Outperform → Sector Perform
Dec-20-24 Initiated Stephens Equal-Weight
Jul-25-24 Resumed B. Riley Securities Buy
Apr-04-24 Initiated JMP Securities Mkt Outperform
Jan-03-24 Initiated Barclays Equal Weight
Feb-02-23 Resumed B. Riley Securities Buy
Nov-01-22 Initiated Stifel Buy
Jul-15-22 Initiated SVB Leerink Outperform
Oct-18-21 Resumed B. Riley Securities Buy
Apr-13-21 Initiated RBC Capital Mkts Outperform
Jan-03-19 Initiated William Blair Outperform
View All

Optimizerx Corp Stock (OPRX) Latest News

pulisher
Jul 22, 2025

How OptimizeRx Corporation stock performs during market volatilityStrong Buy Recommendations - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

Best Growth Stocks to Buy for July 22nd - TradingView

Jul 22, 2025
pulisher
Jul 22, 2025

OptimizeRx Corporation Stock Analysis and ForecastFree High-Return Strategy Alerts - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

OptimizeRx Corp. (NASDAQ:OPRX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat

Jul 22, 2025
pulisher
Jul 22, 2025

What makes OptimizeRx Corporation stock price move sharplyProven High Yield Signals - Newser

Jul 22, 2025
pulisher
Jul 19, 2025

OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

OptimizeRx: Stock Could Rise As Profitability Is Achieved - Seeking Alpha

Jul 18, 2025
pulisher
Jul 18, 2025

Can OPRX's Patient Engagement Tools Win Amid Fierce Competition? - The Globe and Mail

Jul 18, 2025
pulisher
Jul 17, 2025

OptimizeRx Sets Second Quarter 2025 Conference Call for August 7, 2025, at 4:30 p.m. ET - The Globe and Mail

Jul 17, 2025
pulisher
Jul 17, 2025

OptimizeRx Corp. to Host Conference Call for Q2 2025 Financial Results on August 7, 2025 - Quiver Quantitative

Jul 17, 2025
pulisher
Jul 17, 2025

Capstone Lands Major Clean Energy Win: 90% Government-Funded Microturbine Project Shows Long-Term Success - Stock Titan

Jul 17, 2025
pulisher
Jul 16, 2025

OPRX Vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - Barchart.com

Jul 16, 2025
pulisher
Jul 15, 2025

Why OptimizeRx Corporation stock attracts strong analyst attentionFree Risk Assessment Services - Newser

Jul 15, 2025
pulisher
Jul 12, 2025

Calamos Advisors LLC Invests $289,000 in OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat

Jul 12, 2025
pulisher
Jul 11, 2025

OptimizeRx Bets on AI and Workflow Integration: Will This Pay Off? - sharewise.com

Jul 11, 2025
pulisher
Jul 09, 2025

Best Growth Stocks To Buy For July 9th - Barchart.com

Jul 09, 2025
pulisher
Jul 09, 2025

Best Growth Stocks to Buy for July 9th - The Globe and Mail

Jul 09, 2025
pulisher
Jul 04, 2025

Can OptimizeRx Maintain Profit Growth Amid Evolving Pharma Spend? - Zacks Investment Research

Jul 04, 2025
pulisher
Jul 03, 2025

OPRX Shares Rise 69.3% in 3 Months: Time to Bet on the Stock? - sharewise.com

Jul 03, 2025
pulisher
Jul 03, 2025

Janney Montgomery Scott LLC Purchases 39,969 Shares of OptimizeRx Corp. (NASDAQ:OPRX) - MarketBeat

Jul 03, 2025
pulisher
Jun 30, 2025

OptimizeRx Corp. (NASDAQ:OPRX) Position Boosted by Janney Montgomery Scott LLC - Defense World

Jun 30, 2025
pulisher
Jun 27, 2025

3,845 Shares in OptimizeRx Corp. (NASDAQ:OPRX) Bought by GAMMA Investing LLC - Defense World

Jun 27, 2025
pulisher
Jun 25, 2025

Best Growth Stocks to Buy for June 25th - Yahoo Home

Jun 25, 2025
pulisher
Jun 24, 2025

OptimizeRx appoints CEO Steve Silvestro to board of directors - Investing.com India

Jun 24, 2025
pulisher
Jun 24, 2025

OptimizeRx Corp. Appoints Steve Silvestro to its Board of Directors, Effective as of June 20, 2025 - MarketScreener

Jun 24, 2025
pulisher
Jun 20, 2025

Simulmedia and OptimizeRx Announce Partnership from the Cannes Lions - Business Wire

Jun 20, 2025
pulisher
Jun 18, 2025

Calculating The Fair Value Of OptimizeRx Corporation (NASDAQ:OPRX) - Yahoo Finance

Jun 18, 2025
pulisher
Jun 13, 2025

OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Bank of America Corp DE - MarketBeat

Jun 13, 2025
pulisher
Jun 13, 2025

OptimizeRx Co. (NASDAQ:OPRX) Shares Purchased by Bank of America Corp DE - Defense World

Jun 13, 2025
pulisher
Jun 13, 2025

OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Stifel Nicolaus Analyst Says - MarketBeat

Jun 13, 2025
pulisher
Jun 10, 2025

Kalkine : indexnasdaq ixic OptimizeRx Drives Healthcare Tech Communication Shift - Kalkine Media

Jun 10, 2025
pulisher
Jun 10, 2025

OptimizeRx (NASDAQ:OPRX) Given New $16.00 Price Target at Stifel Nicolaus - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

OptimizeRx (OPRX) Price Target Raised by Stifel Analyst | OPRX S - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

OptimizeRx (OPRX) Price Target Raised by Stifel to $16 | OPRX St - GuruFocus

Jun 09, 2025
pulisher
Jun 09, 2025

Stifel raises OptimizeRX stock price target to $16 from $12 By Investing.com - Investing.com South Africa

Jun 09, 2025
pulisher
Jun 09, 2025

Stifel raises OptimizeRX stock price target to $16 from $12 - Investing.com

Jun 09, 2025
pulisher
Jun 09, 2025

OptimizeRx Co. (NASDAQ:OPRX) Shares Bought by Squarepoint Ops LLC - Defense World

Jun 09, 2025
pulisher
Jun 06, 2025

Here's Why OptimizeRx Corp. (OPRX) is a Great Momentum Stock to Buy - sharewise

Jun 06, 2025
pulisher
Jun 05, 2025

OptimizeRx Corp (OPRX) Stock Price Up 6.89% on Jun 5 - GuruFocus

Jun 05, 2025
pulisher
Jun 04, 2025

New Strong Buy Stocks for June 4th - TradingView

Jun 04, 2025

Optimizerx Corp Stock (OPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Optimizerx Corp Stock (OPRX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Silvestro Stephen L
Chief Commercial Officer
Mar 01 '25
Option Exercise
0.00
1,928
0
121,886
Odence-Ford Marion
Chief Legal Officer & CHRO
Mar 01 '25
Option Exercise
0.00
771
0
70,544
KLEMA CATHY
Director
Feb 02 '25
Option Exercise
0.00
5,109
0
11,752
Odence-Ford Marion
General Counsel and CCO
Dec 19 '24
Option Exercise
0.00
3,927
0
28,383
Silvestro Stephen L
Chief Commercial Officer
Dec 19 '24
Option Exercise
0.00
6,546
0
83,424
Besch Doug
Chief Product Officer
Dec 19 '24
Option Exercise
0.00
1,964
0
12,160
Stelmakh Edward
CFO/COO
Dec 19 '24
Option Exercise
0.00
5,237
0
38,603
FEBBO WILLIAM J
CEO
Dec 12 '24
Buy
5.01
20,000
100,220
601,253
Odence-Ford Marion
General Counsel and CCO
Nov 08 '24
Option Exercise
0.00
1,785
0
24,980
Stelmakh Edward
CFO/COO
Oct 11 '24
Option Exercise
0.00
8,222
0
35,432
$10.80
price up icon 1.69%
$21.39
price up icon 1.33%
$20.30
price up icon 1.15%
$47.05
price up icon 0.79%
$21.30
price up icon 5.71%
health_information_services WAY
$36.96
price up icon 1.07%
Cap:     |  Volume (24h):